Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Exclusion Criteria

• •Receipt of effective antibacterial drug therapy for cUTI for more than 24 hours during the previous 72 hours prior to randomization
• •A urine culture result is resistant to meropenem or a gram negative pathogen is not identified or more than 2 microorganisms are isolated or a confirmed fungal UTI is identified
• •Required use of nonstudy systemic bacterial therapy
• •Suspected or confirmed prostatitis or urinary tract symptoms attributable to sexually transmitted disease
• •Patients with perinephric or renal abscess
• •Patients with renal transplantation or receiving hemodialysis or peritoneal dialysis
• •Abnormal labs